Literature DB >> 12766948

Fanconi anaemia proteins: major roles in cell protection against oxidative damage.

Giovanni Pagano1, Hagop Youssoufian.   

Abstract

Fanconi anaemia (FA) is a cancer-prone genetic disorder that is characterised by cytogenetic instability and redox abnormalities. Although rare subtypes of FA (B, D1 and D2) have been implicated in DNA repair through links with BRCA1 and BRCA2, such a role has yet to be demonstrated for gene products of the common subtypes. Instead, these products have been strongly implicated in xenobiotic metabolism and redox homeostasis through interactions of FANCC with cytochrome P-450 reductase and with glutathione S-transferase, and of FANCG with cytochrome P-450 2E1, as well as redox-dependent signalling through an interaction between FANCA and Akt kinase. We hypothesise that FA proteins act directly (via FANCC and FANCG) and indirectly (via FANCA, BRCA2 and FANCD2) with the machinery of cellular defence to modulate oxidative stress. The latter interactions may co-ordinate the link between the response to DNA damage and oxidative stress parameters (3, 6-12). Copyright 2003 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12766948     DOI: 10.1002/bies.10283

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  18 in total

1.  Molecular cross-talk among chromosome fragility syndromes.

Authors:  Jordi Surrallés; Stephen P Jackson; Maria Jasin; Michael B Kastan; Stephen C West; Hans Joenje
Journal:  Genes Dev       Date:  2004-06-15       Impact factor: 11.361

2.  Normal red blood cells partially decrease diepoxybutane-induced chromosome breakage in cultured lymphocytes from Fanconi anaemia patients.

Authors:  B Porto; R Sousa; I Malheiro; J Gaspar; J Rueff; C Gonçalves; J Barbot
Journal:  Cell Prolif       Date:  2010-12       Impact factor: 6.831

3.  Formation of cyclophosphamide specific DNA adducts in hematological diseases.

Authors:  L'Aurelle A Johnson; Bhaskar Malayappan; Natalia Tretyakova; Colin Campbell; Margaret L MacMillan; John E Wagner; Pamala A Jacobson
Journal:  Pediatr Blood Cancer       Date:  2011-07-25       Impact factor: 3.167

Review 4.  Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.

Authors:  Anna Petryk; Roopa Kanakatti Shankar; Neelam Giri; Anthony N Hollenberg; Meilan M Rutter; Brandon Nathan; Maya Lodish; Blanche P Alter; Constantine A Stratakis; Susan R Rose
Journal:  J Clin Endocrinol Metab       Date:  2015-01-09       Impact factor: 5.958

5.  Enhanced TNF-alpha-induced apoptosis in Fanconi anemia type C-deficient cells is dependent on apoptosis signal-regulating kinase 1.

Authors:  Khadijeh Bijangi-Vishehsaraei; M Reza Saadatzadeh; Adam Werne; Kristina A Wilson McKenzie; Reuben Kapur; Hidenori Ichijo; Laura S Haneline
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

6.  The E1A-associated p400 protein modulates cell fate decisions by the regulation of ROS homeostasis.

Authors:  Lise Mattera; Céline Courilleau; Gaëlle Legube; Takeshi Ueda; Rikiro Fukunaga; Martine Chevillard-Briet; Yvan Canitrot; Fabrice Escaffit; Didier Trouche
Journal:  PLoS Genet       Date:  2010-06-10       Impact factor: 5.917

Review 7.  Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: mechanistic insights.

Authors:  Larry H Thompson; John M Hinz
Journal:  Mutat Res       Date:  2009-02-21       Impact factor: 2.433

8.  Coordinate regulation of Fanconi anemia gene expression occurs through the Rb/E2F pathway.

Authors:  E E Hoskins; R W Gunawardena; K B Habash; T M Wise-Draper; M Jansen; E S Knudsen; S I Wells
Journal:  Oncogene       Date:  2008-04-28       Impact factor: 9.867

Review 9.  Genetic instability syndromes with progeroid features.

Authors:  K Neveling; A Bechtold; H Hoehn
Journal:  Z Gerontol Geriatr       Date:  2007-10       Impact factor: 1.281

10.  In vivo repopulation ability of genetically corrected bone marrow cells from Fanconi anemia patients.

Authors:  Odile Cohen-Haguenauer; Bruno Péault; Cécile Bauche; Marie-Thérèse Daniel; Ibrahim Casal; Vincent Levy; Jean Dausset; Michel Boiron; Christian Auclair; Eliane Gluckman; Michel Marty
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.